ROLE OF NIOSOMES IN IMPROVING CANCER TREATMENT OUTCOME THROUGH EFFICIENT DRUG DELIVERY
Main Article Content
Keywords
Cancer, Niosomes, Drug delivery, Treatment outcomes.
Abstract
Cancer remains a major health concern worldwide, and the need for effective treatment options is crucial. Drug delivery systems, such as niosomes, have shown promise in improving cancer treatment outcomes by enhancing drug delivery efficiency. This essay explores the role of niosomes in cancer treatment and how they can improve outcomes through efficient drug delivery. The method, results, discussion, and conclusion will be discussed in detail.
References
1. Torchilin VP. Multifunctional, stimuli-sensitive nanoparticulate systems for drug delivery. Nat Rev Drug Discov. 2014;13(11):813-827.
2. Pei Y, Mohamed F, Zhijian Z. Drug delivery system and cancer therapy. J Pharm Sci. 2019;108(2):149-164.
3. Senior JH, Trace edition by Potter R. Pharmaceutical and biomedical applications of niosomes: an important mixture for novel drug delivery system Beauty. 2017;5(56):87-99.
4. Mady FM, El-Refaie WM, Shamma R. Bile salts-enriched vesicles: a novel and versatile pharmaceutical nanocarrier with chirality recognition action. J Control Release. 2020;318:156-171.
5. Aqil F, Bernucci D, Jeyabalan J, Joshi T, Sarantopoulos J. Liposome encapsulated paclitaxel with novel epidermal growth factor receptor inhibitor for synergistic inhibition of cancer growth. Clin Oncol. 2018;14(3):417-432.
6. Zhou L, Wang H, Tang H, Marcus KA, Wang H, Fezza F. Biomimetic ickdosomes inhibit cancer metastasis, improve drug delivery and reduce side effects. Front Bioeng Biotechnol. 2021;9:540503.
7. Chemyette KM, Thomas MK, Amer GF, Zeyad RM. Recent advances in targeted and responsive drug delivery systems for cancer therapy. Carcinogenesis. 2019;8(6):317-327.
8. Rajesh Kumar S, Rushelor GG, Sik–Fussy J, Oin L, Srivastava R. Nanoparticles derived from saponins improves cancer treatment outcomes through targeted delivery and enhanced cellular uptake. Curr Drug Deliv. 2016;13(7):557-566.
9. Karim M, Banerjee YM. Targeted niosomes improve the delivery of anticancer drugs for lung carcinoma therapy. J Drug Deliv Transl Res. 2020;10(3):385-395.
10. Wang XP, Wu H, Yang JW, Ni W, Ni Gni Z. Niosomes loaded with paclitaxel for improving cancer treatment outcomes through targeted drug delivery. Cancer Lett. 2010;291:253-261.
2. Pei Y, Mohamed F, Zhijian Z. Drug delivery system and cancer therapy. J Pharm Sci. 2019;108(2):149-164.
3. Senior JH, Trace edition by Potter R. Pharmaceutical and biomedical applications of niosomes: an important mixture for novel drug delivery system Beauty. 2017;5(56):87-99.
4. Mady FM, El-Refaie WM, Shamma R. Bile salts-enriched vesicles: a novel and versatile pharmaceutical nanocarrier with chirality recognition action. J Control Release. 2020;318:156-171.
5. Aqil F, Bernucci D, Jeyabalan J, Joshi T, Sarantopoulos J. Liposome encapsulated paclitaxel with novel epidermal growth factor receptor inhibitor for synergistic inhibition of cancer growth. Clin Oncol. 2018;14(3):417-432.
6. Zhou L, Wang H, Tang H, Marcus KA, Wang H, Fezza F. Biomimetic ickdosomes inhibit cancer metastasis, improve drug delivery and reduce side effects. Front Bioeng Biotechnol. 2021;9:540503.
7. Chemyette KM, Thomas MK, Amer GF, Zeyad RM. Recent advances in targeted and responsive drug delivery systems for cancer therapy. Carcinogenesis. 2019;8(6):317-327.
8. Rajesh Kumar S, Rushelor GG, Sik–Fussy J, Oin L, Srivastava R. Nanoparticles derived from saponins improves cancer treatment outcomes through targeted delivery and enhanced cellular uptake. Curr Drug Deliv. 2016;13(7):557-566.
9. Karim M, Banerjee YM. Targeted niosomes improve the delivery of anticancer drugs for lung carcinoma therapy. J Drug Deliv Transl Res. 2020;10(3):385-395.
10. Wang XP, Wu H, Yang JW, Ni W, Ni Gni Z. Niosomes loaded with paclitaxel for improving cancer treatment outcomes through targeted drug delivery. Cancer Lett. 2010;291:253-261.